Contract research news in brief
November 22, 2011Manufacturing and Production manufacturing and production
UCB forges strategic alliances with Parexel and PRA, Icon wins a contract for a phase III trial of a traditional …
AstraZeneca appoints two new senior leaders in its Americas division
November 22, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca
AstraZeneca has appointed Rich Fante as regional vice president of the Americas, and Marion McCourt as chief operating officer of …
Thomas Thorp promoted to senior director of corporate affairs at Lilly UK
November 22, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing lilly
Thomas Thorp has been promoted to senior director of corporate affairs at Lilly UK. Thorp will now lead all of …
Lucentis rival gains US approval
November 22, 2011Research and Development, Sales and Marketing Bayer, Eylea, Lucentis, Novartis, Regeneron, Roche
A rival to Roche and Novartis’ drug Lucentis has received FDA approval for a common form of eye disease. Eylea …
Gilead aims for hep C lead with Pharmasset acquisition
November 22, 2011Research and Development Gilead, HCV, Pharmasset, Victrelis, hepatitis C
Gilead Sciences is to buy Pharmasset for $11 billion in a bid to become a leader in hepatitis C treatment.The …
Celgene opens new headquarters in UK
November 21, 2011Research and Development, Sales and Marketing Celgene
Celgene has opened new UK headquarters in London as its haematology-based business expands. The firm says it has decided to …
Update on the planned consolidation of UK medicines legislation
November 21, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Earlier this year we reported on progress in the consolidation of the UK medicines legislation and that the Medicines and …
EMA accepts submission of Pfizer’s new arthritis drug
November 21, 2011Research and Development, Sales and Marketing EMA, Pfizer, tofacitinib
The European Medicines Agency has accepted Pfizer’s arthritis drug tofacitinib for review.Tofacitinib is a novel, oral JAK inhibitor being studied …
Andreas Pott appointed deputy executive director of European Medicines Agency
November 21, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Europe
The European Medicines Agency’s new executive director Guido Rasi has appointed Andreas Pott as deputy executive director. Pott’s appointment follows …
FDA pulls Roche’s Avastin for breast cancer
November 21, 2011Research and Development, Sales and Marketing FDA, Roche, avastin
The FDA has pulled Avastin’s breast cancer licence in the US after the drug failed to prove its safety and …
Dipankar Bhattacharjee becomes vice president of Teva Northern Europe
November 21, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva
Dipankar Bhattacharjee has been promoted to vice president of UK and Teva Northern Europe. Teva said that as part of …
Manufacturing drives growth at Wuxi Pharmatech
November 21, 2011Manufacturing and Production WuXi PharmaTech
Chinese outsourcing services specialist WuXi Pharmatech reported a 24% increase in third-quarter sales to $104 million thanks to a robust …
Novartis workers stage flash strike over job cuts
November 21, 2011Manufacturing and Production Novartis, Switzerland, job cuts
Workers at Novartis’ Nyon facility in Switzerland carried out a strike to protest the closure of the plant, but called …
AstraZeneca’s thyroid cancer drug gets CHMP nod
November 21, 2011Sales and Marketing AstraZeneca, CHMP, Caprelsa, vandetanib
AstraZeneca’s thyroid cancer pill Caprelsa has taken a step closer to European approval after being recommended by the CHMP.Caprelsa (vandetanib) …
AstraZeneca’s UK research centre prepares to close
November 18, 2011Research and Development AstraZeneca, Charnwood
AstraZeneca has thrown more light on the pending closure of its UK R&D site in Charnwood, saying that 90% of …
First stem cell trial halted due to costs
November 18, 2011Research and Development Geron, Stem cells
One of the world’s first stem cell trials has been put on hold due to ‘uncertain economic conditions’.Geron, the firm undertaking …
Bayer forecasts €11 billion growth in Asia
November 17, 2011Bayer, China, emerging markets
Bayer is expecting sales in Asia to grow by €11 billion over the next four years, with over half of …
Industry supports bid to revitalise antibiotic research
November 17, 2011Research and Development, Sales and Marketing EFPIA, Europe, IMI, antibiotic
The European Commission and the European pharma industry have unveiled plans to accelerate the discovery and development of new antibiotics. …
Jeremy Poland
November 17, 2011Sales and Marketing MSI Consultancy
Pharmaceutical consultancy firm The MSI Consultancy has appointed Jeremy Poland as a Graduate Analyst in its Marketing Sciences division. Jeremy …
Latest content
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
